The results demonstrated that cisatracurium besilate enhanced the TRAIL-induced apoptosis of GC cells via p53 signaling, suggesting that cisatracurium besilate increased the sensitivity of TRAIL to amplify the therapeutic efficacy of itself in GC management. Here, TNFSF10 is linked to gastric cancer.